Infectious Diseases
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. 
Subscribe to this data using MyMedWorm.
Subscribe to this data using GoogleReader.
Subscribe to this data using Bloglines.
Subscribe to this data using MyYahoo.
Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.
This page shows you the most recent publications within this specialty of the MedWorm directory. This is page number 12.
An outbreak of hospital-acquired Staphylococcus aureus skin infection among newborns, Nan Province, Thailand, January 2008.
Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
In January 2008, we investigated a cluster of neonates with bullous impetigo in a hospital of northern Thailand in order to control the outbreak and identify a potential source of the infection. We reviewed medical records and working timetables of healthcare workers (HCWs) and conducted a case-control study. We performed an environmental study and took bacteriological samples from HCWs and equipments. According to our case definitions, we identified 16 confirmed cases and 14 probable cases. The attack rate was 42%. Most cases had skin blisters (28 cases) followed by pustules (five cases) and exfoliation (three cases)....
Source: Euro Surveill - November 6, 2009 Category: Infectious Diseases Authors: Pawun V, Jiraphongsa C, Puttamasute S, Putta R, Wongnai A, Jaima T, Tithsayatikom P, Wattanasri S Tags: Euro Surveill Source Type: journals
Estimating diagnostic accuracy of tests for latent tuberculosis infection without a gold standard among healthcare workers.Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
In conclusion, when used in healthcare workers, in vitro assays may provide a significant increase of specificity for tuberculosis infection compared to TST, even among non vaccinated individuals, at the cost of some sensitivity.
PMID: 19883555 [PubMed - in process]
Source: Euro Surveill - November 6, 2009 Category: Infectious Diseases Authors: Girardi E, Angeletti C, Puro V, Sorrentino R, Magnavita N, Vincenti D, Carrara S, Butera O, Ciufoli AM, Squarcione S, Ippolito G, Goletti D Tags: Euro Surveill Source Type: journals
Pandemic H1N1 influenza lessons from the southern hemisphere.Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
PMID: 19883551 [PubMed - in process]
Source: Euro Surveill - November 6, 2009 Category: Infectious Diseases Authors: Baker M, Kelly H, Wilson N Tags: Euro Surveill Source Type: journals
Preliminary analysis of the pandemic H1N1 influenza on Reunion Island (Indian Ocean): surveillance trends (July to mid-September 2009).Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
We report preliminary epidemiological characteristics of the pandemic on Reunion Island in 2009 until week 37 ending September 13.
PMID: 19883550 [PubMed - in process]
Source: Euro Surveill - November 6, 2009 Category: Infectious Diseases Authors: Thouillot F, Do C, Balleydier E, Rachou E, Staikowsky F, Morbidelli P, Jacques-Antoine Y, Bourde A, Lagrange-Xelot M, Poubeau P, Winer A, Gauzere B, Michault A, Jaffar-Bandjee M, Henrion G, Filleul L, D Ortenzio E Tags: Euro Surveill Source Type: journals
Interim report on pandemic H1N1 influenza virus infections in South Africa, April to October 2009: epidemiology and factors associated with fatal cases.Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
We provide an interim report on pandemic H1N1 influenza activity in South Africa, with a focus on the epidemiology and factors associated with deaths. Following the importation of the virus on 14 July 2009, and the epidemic peak during the week starting 3 August, the incidence in South Africa has declined. A total of 12,331 cases and 91 deaths have been laboratory-confirmed as of 12 October 2009. Age distribution and risk groups were similar to those observed elsewhere. The median age of patients who died (33.5 years) was significantly higher than that of the non-fatal cases (15.0 years, p<0.01). The most common und...
Source: Euro Surveill - November 6, 2009 Category: Infectious Diseases Authors: Archer B, Cohen C, Naidoo D, Thomas J, Makunga C, Blumberg L, Venter M, Timothy G, Puren A, McAnerney J, Cengimbo A, Schoub B Tags: Euro Surveill Source Type: journals
Pandemic H1N1 influenza in Brazil: analysis of the first 34,506 notified cases of influenza-like illness with severe acute respiratory infection (SARI).Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
We report an analysis of the first 34,506 cases of influenza-like illness with severe acute respiratory infection (SARI) notified in Brazil during the epidemiological weeks 16 to 33. The 5,747 confirmed cases of pandemic H1N1 influenza showed two incidence peaks across the age span: one in children up to the age of five years (3.8/100,000) and one in individuals aged 20 to 29 years (4.6/100,000). People over the age of 60 had the lowest incidence (1.1/100,000 inhabitants). The epidemic peaked rapidly. Ninety-four percent of cases were concentrated in two of Brazil s five geographic regions - the south and southeast, region...
Source: Euro Surveill - November 6, 2009 Category: Infectious Diseases Authors: Oliveira W, Carmo E, Penna G, Kuchenbecker R, Santos H, Araujo W, Malaguti R, Duncan B, Schmidt M, Tags: Euro Surveill Source Type: journals
Pandemic influenza in a southern hemisphere setting: the experience in Peru from May to September, 2009.Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
This paper presents a description of Peru s experience with pandemic H1N1 influenza 2009. It is based on data from four main surveillance systems: a) ongoing sentinel surveillance of influenza-like illness cases with virological surveillance of influenza and other respiratory viruses; b) sentinel surveillance of severe acute respiratory infections and associated deaths; c) surveillance of acute respiratory infections in children under the age of five years and pneumonia in all age groups; and d) case and cluster surveillance. On 9 May 2009, the first confirmed case of pandemic H1N1 influenza in Peru was diagnosed in a ...
Source: Euro Surveill - November 6, 2009 Category: Infectious Diseases Authors: Gomez J, Munayco C, Arrasco J, Suarez L, Laguna-Torres V, Aguilar P, Chowell G, Kochel T Tags: Euro Surveill Source Type: journals
Progression and impact of the first winter wave of the 2009 pandemic H1N1 influenza in New South Wales, Australia.Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Authors:
A range of surveillance systems were used to assess the progression and impact of the first wave of pandemic H1N1 influenza in New South Wales, Australia during the southern hemisphere winter. Surveillance methods included laboratory notifications, near real-time emergency department syndromic surveillance, ambulance despatch surveillance, death certificate surveillance and purpose-built web-based data systems to capture influenza clinic and intensive care unit activity. The epidemic lasted 10 weeks. By 31 August 2009, 1,214 people with pandemic H1N1 influenza infection were hospitalised (17.2 per 100,000 po...
Source: Euro Surveill - November 6, 2009 Category: Infectious Diseases Tags: Euro Surveill Source Type: journals
Pandemic H1N1 influenza surveillance in Victoria, Australia, April - September, 2009.Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Victoria was the first Australian state to report widespread transmission of pandemic H1N1 2009 influenza. Notifiable laboratory-confirmed influenza and a general practitioner sentinel surveillance system measuring influenza-like illness (ILI), including laboratory confirmation of influenza as the cause of ILI, were used to assess the pandemic. The pandemic influenza A(H1N1)v virus quickly became the dominant circulating strain and notification rates were highest in children and young adults. Despite a high number of notified cases, comparison of ILI rates suggested the season peaked in late June, was similar in magnit...
Source: Euro Surveill - November 6, 2009 Category: Infectious Diseases Authors: Fielding J, Higgins N, Gregory J, Grant K, Catton M, Bergeri I, Lester R, Kelly H Tags: Euro Surveill Source Type: journals
Early transmission characteristics of influenza A(H1N1)v in Australia: Victorian state, 16 May - 3 June 2009.Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Australia was one of the first countries of the southern hemisphere to experience influenza A(H1N1)v with community transmission apparent in Victoria, Australia, by 22 May 2009. With few identified imported cases, the epidemic spread through schools and communities leading to 897 confirmed cases by 3 June 2009. The estimated reproduction ratio up to 31 May 2009 was 2.4 (95% credible interval (CI): 2.1-2.6). Methods designed to account for undetected transmission reduce this estimate to 1.6 (95% CI: 1.5-1.8). Time varying reproduction ratio estimates show a steady decline in observed transmission over the first 14 days ...
Source: Euro Surveill - November 6, 2009 Category: Infectious Diseases Authors: McBryde E, Bergeri I, van Gemert C, Rotty J, Headley E, Simpson K, Lester R, Hellard M, Fielding J Tags: Euro Surveill Source Type: journals
The 2009 pandemic H1N1 influenza and indigenous populations of the Americas and the Pacific.Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
There are few structured data available to assess the risks associated with pandemic influenza A(H1N1)v infection according to ethnic groups. In countries of the Americas and the Pacific where these data are available, the attack rates are higher in indigenous populations, who also appear to be at approximately three to six-fold higher risk of developing severe disease and of dying. These observations may be associated with documented risk factors for severe disease and death associated with pandemic H1N1 influenza infection (especially the generally higher prevalence of diabetes, obesity, asthma, chronic obstructive ...
Source: Euro Surveill - November 6, 2009 Category: Infectious Diseases Authors: La Ruche G, Tarantola A, Barboza P, Vaillant L, Gueguen J, Gastellu-Etchegorry M, Tags: Euro Surveill Source Type: journals
Use of an inactivated vaccine in mitigating pandemic influenza A(H1N1) spread: a modelling study to assess the impact of vaccination timing and prioritisation strategies.Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The impact of prioritization and of timing of vaccination strategies on reducing transmission of pandemic influenza A(H1N1) was evaluated in a community with the structure of the Greek population using a stochastic simulation model. Prioritization scenarios were based on the recommendations of the United States Centers for Disease Control and Prevention Advisory Committee on Immunization Practices and vaccination was assumed to initiate either before or during the ongoing epidemic. In the absence of intervention, an illness attack rate (AR) of 34.5% is anticipated. Vaccinating the priority groups before the epidemic (p...
Source: Euro Surveill - November 6, 2009 Category: Infectious Diseases Authors: Sypsa V, Pavlopoulou I, Hatzakis A Tags: Euro Surveill Source Type: journals
Pandemic H1N1 influenza: predicting the course of a pandemic and assessing the efficacy of the planned vaccination programme in the United States.Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
We use data on confirmed cases of pandemic influenza A(H1N1), disseminated by the United States Centers for Disease Control and Prevention(US CDC), to fit the parameters of a seasonally forced Susceptible, Infective, Recovered (SIR) model. We use the resulting model to predict the course of the H1N1 influenza pandemic in autumn 2009, and we assess the efficacy of the planned CDC H1N1 vaccination campaign. The model predicts that there will be a significant wave in autumn, with 63% of the population being infected, and that this wave will peak so early that the planned CDC vaccination campaign will likely not have a lar...
Source: Euro Surveill - November 6, 2009 Category: Infectious Diseases Authors: Towers S, Feng Z Tags: Euro Surveill Source Type: journals
Resistance of turkeys to experimental infection with an early 2009 Italian human influenza A(H1N1)v virus isolate.Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
We performed an experimental infection of 21- and 70-day-old meat turkeys with an early human isolate of the 2009 pandemic H1N1 influenza virus exhibiting an alpha-2,3 receptor binding profile. Virus was not recovered by molecular or conventional methods from blood, tracheal and cloacal swabs, lungs, intestine or muscle tissue. Seroconversion was detected in a limited number of birds with the homologous antigen only. Our findings suggest that in its present form, the pandemic H1N1 influenza virus is not likely to be transmitted to meat turkeys and does therefore not represent an animal health or food safety issue for t...
Source: Euro Surveill - November 6, 2009 Category: Infectious Diseases Authors: Terregino C, De Nardi R, Nisi R, Cilloni F, Salviato A, Fasolato M, Capua I Tags: Euro Surveill Source Type: journals
Pandemic influenza A(H1N1) 2009 vaccines in the European Union.Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Pandemic vaccines from four manufacturers are now available for use within the European Union (EU). Use of these vaccines will protect individuals and reduce the impact on health services to more manageable levels. The majority of the severely ill will be from known risk groups and the best strategy will be to start vaccinating in line with the recommendation from the European Union Health Security Committee prioritizing adults and children with chronic conditions, pregnant women and healthcare workers. The composition of authorized vaccines is reviewed in this article. The vaccine strain in all authorized pandemic vac...
Source: Euro Surveill - November 6, 2009 Category: Infectious Diseases Authors: Johansen K, Nicoll A, Ciancio BC, Kramarz P Tags: Euro Surveill Source Type: journals
A foodborne outbreak of norovirus gastroenteritis associated with a Christmas dinner in Porto, Portugal, December 2008.Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
An outbreak of acute norovirus gastroenteritis was detected and epidemiologically linked to a Christmas dinner reunion of 22 recent graduate students in a restaurant in Porto, Portugal, in December 2008. A retrospective cohort study was carried out using online standardised questionnaires. Sixteen primary and three secondary cases were identified and the risk ratios with 95% confidence intervals for each food item were calculated. The response rate to the online questionnaires was 96%. The outbreak met all four Kaplan s criteria and the attack rate was 73%. Norovirus GII.4 2006b was detected in stools and emesis sample...
Source: Euro Surveill - November 6, 2009 Category: Infectious Diseases Authors: Mesquita JR, Nascimento MS Tags: Euro Surveill Source Type: journals
Interference between outbreaks of respiratory viruses.Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
PMID: 19883536 [PubMed - in process]
Source: Euro Surveill - November 6, 2009 Category: Infectious Diseases Authors: Anestad G, Nordbo SA Tags: Euro Surveill Source Type: journals
Africa: Drug Subsidy Key to Anti-Malaria EffortEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Just three percent of malaria-infected children in Africa get World Health Organisation-recommended drugs. One expert has equated this to a death sentence for sick children.
Source: AllAfrica News: Malaria - November 6, 2009 Category: Infectious Diseases Source Type: news
1 December NewsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Clinical Infectious Diseases, Volume 49, Issue 11, Page i-ii, 1 December 2009.
Source: Clinical Infectious Diseases Latest Issue - November 6, 2009 Category: Infectious Diseases Tags: article 1 December Source Type: journals
A Listeria monocytogenes Strain Is Still Virulent despite Nonfunctional Major Virulence GenesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
This study aimed to characterize the A23 strain, which exhibits a pulsed‐field gel electrophoresis profile specific to low‐virulence strains. This strain has the same causal mutations as the group III strains and a supplementary mutation in the mpl gene, leading to the absence of internalin A expression and the presence of inactive internalin B, phosphatidyl‐inositol phospholipase C, and phosphatidylcholine phospholipase C. Despite these mutations in major virulence genes, the A23 strain formed plaques in cell monolayers and contaminated 100% of inoculated mice, suggesting that it evolved from group III strains by ac...
Source: The Journal of Infectious Diseases Latest Issue - November 6, 2009 Category: Infectious Diseases Tags: article BRIEF REPORT Source Type: journals
BioAlliance Pharma Presents Additional US Pivotal Phase III Results On Loramyc™ (Miconazole Lauriad(R)) At The 47Th Annual Meeting Of The IDSAEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
BioAlliance Pharma SA (Paris:BIO), a company dedicated to the treatment and supportive care of cancer and AIDS patients, has presented results on miconazole Lauriad® at the 47th Annual Meeting of the Infectious Diseases Society of America (IDSA) in Philadelphia (October 29 - November 1st).
Source: Infectious Diseases / Bacteria / Viruses News From Medical News Today - November 6, 2009 Category: Infectious Diseases Tags: Infectious Diseases / Bacteria / Viruses Source Type: news
Antiretroviral activity of the aminothiol WR1065 against Human Immunodeficiency virus (HIV-1) in vitro and Simian Immunodeficiency virus (SIV) ex vivoEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Conclusion:
The study demonstrates that WR1065 and the parent drug amifostine, the FDA-approved drug Ethyol, have antiretroviral activity. WR1065 was active against both an acute infection of HIV-1 and a chronic infection of SIV. The data suggest that the non-toxic drug amifostine may be a useful antiretroviral agent given either alone or in combination with other drugs as adjuvant therapy.
Source: AIDS Research and Therapy - November 6, 2009 Category: Infectious Diseases Authors: Miriam PoirierOfelia OliveroAndrew HardyGenoveffa FranchiniJennifer BorojerdiVernon WalkerDale WalkerGene Shearer Source Type: journals
Participate in the AIDS.gov World AIDS Day Conference CallEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
AIDS.gov is hosting a conference call to provide Federal staff and grantees an update on the state of the HIV/AIDS epidemic in the United States and a brief overview of the global epidemic.
Capacity is limited to the first 3,500 callers, and participants must register by November 15. A podcast and transcript will be available shortly after the call on the AIDS.gov Web site.
More information is available:
Read the conference call announcement
Visit AIDS.gov to register for the call
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - November 6, 2009 Category: Infectious Diseases Source Type: info
Challenges and Approaches to Future HIV Research OutlinedEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
“In a new article in Health Affairs, Anthony S. Fauci, M.D. and Gregory K. Folkers, M.S., M.P.H., discuss the urgent imperative both to scale up proven tools of HIV treatment and prevention, and to develop bold new interventions—from curative therapies to vaccines and other new prevention modalities. Dr. Fauci is director of the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health. Mr. Folkers is health scientist and chief of staff in the Immediate Office of the Director, NIAID.“The authors note that only a fraction of people who need HIV treatment, prevention and r...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - November 6, 2009 Category: Infectious Diseases Source Type: info
Study of Investigational Integrase Inhibitor in Healthy Volunteers Indicates SafetyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
“S/GSK1349572 is a novel integrase inhibitor with potent in vitro anti-HIV activity, a different in vitro resistance profile than other integrase inhibitors, and a favorable preclinical safety and pharmacokinetics (PK).…In the single-dose study, 2 cohorts of 10 subjects (8 active, 2 placebo) received suspension doses of 2, 5, 10, 25, 50 and 100 mg in an alternating panel design. In the multiple-dose study, 3 cohorts of 10 subjects (8 active, 2 placebo) received suspension doses of 10, 25 and 50 mg once daily for 10 days....S/GSK1349572 was well tolerated. Most adverse events (AEs) were mild, with few moderate AEs repor...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - November 6, 2009 Category: Infectious Diseases Source Type: info
Larger Foreskin Surface Area Linked to Increased Risk of HIV Infection in MenEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
“Male circumcision reduces HIV acquisition in men. We assessed whether foreskin surface area was associated with HIV acquisition prior to circumcision….In two randomized trials of male circumcision, the surface area of the foreskin was measured after surgery using standardized procedures. Nine hundred and sixty-five initially HIV-negative men were enrolled in a community cohort who subsequently enrolled in the male circumcision trials, provided 3920.8 person-years of observation prior to circumcision. We estimated HIV incidence per 100 person-years prior to circumcision, associated with foreskin surface area categorize...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - November 6, 2009 Category: Infectious Diseases Source Type: info
Antiretroviral activity of the aminothiol WR1065 against Human Immunodeficiency virus (HIV-1) in vitro and Simian Immunodeficiency virus (SIV) ex vivo.Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
CONCLUSION: The study demonstrates that WR1065 and the parent drug amifostine, the FDA-approved drug Ethyol, have antiretroviral activity. WR1065 was active against both an acute infection of HIV-1 and a chronic infection of SIV. The data suggest that the non-toxic drug amifostine may be a useful antiretroviral agent given either alone or in combination with other drugs as adjuvant therapy.
PMID: 19895691 [PubMed - as supplied by publisher]
Source: AIDS Research and Therapy - November 6, 2009 Category: Infectious Diseases Authors: Poirier MC, Olivero OA, Hardy AW, Franchini G, Borojerdi JP, Walker VE, Walker DM, Shearer GM Tags: AIDS Res Ther Source Type: journals
Specific Chemotherapy of Chagas Disease: Relevance, Current Limitations and New Approaches.Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
A critical review of the development of specific chemotherapeutic approaches for the management of American Trypanosomiasis or Chagas disease is presented, including controversies on the pathogenesis of the disease, the initial efforts that led to the development of currently available drugs (nifurtimox and benznidazole), limitations of these therapies and novel approaches for the development of anti-Trypanosoma cruzi drugs, based on our growing understanding of the biology of this parasite. Among the later, the most promising approaches are ergosterol biosynthesis inhibitors such as posaconazole and ravuconazole, pois...
Source: Acta Tropica - November 6, 2009 Category: Infectious Diseases Authors: Urbina JA Tags: Acta Trop Source Type: journals
Questions and Answers about 2009 H1N1 in pets.Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Source: CDC Swine Flu Updates - November 5, 2009 Category: Infectious Diseases Source Type: organizations
Questions and Answers about 2009 H1N1 in petsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
What animals can be infected with the 2009 H1N1 virus? How do companion animals become infected with 2009 H1N1? Can I get 2009 H1N1 influenza from my pet? Is there a vaccine available for my pet?
Source: CDC Swine Flu Updates - November 5, 2009 Category: Infectious Diseases Source Type: organizations
Emerging Infections: Transmission of Human Infection with Nipah VirusEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Clinical Infectious Diseases, Volume 49, Issue 11, Page 1743-1748, 1 December 2009.
Nipah virus (NiV) is a paramyxovirus whose reservoir host is fruit bats of the genus Pteropus. Occasionally the virus is introduced into human populations and causes severe illness characterized by encephalitis or respiratory disease. The first outbreak of NiV was recognized in Malaysia, but 8 outbreaks have been reported from Bangladesh since 2001. The primary pathways of transmission from bats to people in Bangladesh are through contamination of raw date palm sap by bats with subsequent consumption by humans and through infection of...
Source: Clinical Infectious Diseases Latest Issue - November 5, 2009 Category: Infectious Diseases Tags: article EMERGING INFECTIONS Source Type: journals
Critically Ill HIV‐Infected Patients: The Particular Case of Tuberculosis‐Associated Immune Reconstitution Inflammatory SyndromeEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Clinical Infectious Diseases, Volume 49, Issue 11, Page 1773-1774, 1 December 2009.
Source: Clinical Infectious Diseases Latest Issue - November 5, 2009 Category: Infectious Diseases Tags: article CORRESPONDENCE Source Type: journals
In the LiteratureEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Clinical Infectious Diseases, Volume 49, Issue 11, Page iii-iv, 1 December 2009.
Source: Clinical Infectious Diseases Latest Issue - November 5, 2009 Category: Infectious Diseases Tags: article 1 December Source Type: journals
Reply to TarchiniEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Clinical Infectious Diseases, Volume 49, Issue 11, Page 1773, 1 December 2009.
Source: Clinical Infectious Diseases Latest Issue - November 5, 2009 Category: Infectious Diseases Tags: article CORRESPONDENCE Source Type: journals
A Pregnant Woman with Severe Diarrhea: (Answer on pages 1767–8)Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Clinical Infectious Diseases, Volume 49, Issue 11, Page 1742, 1 December 2009.
Source: Clinical Infectious Diseases Latest Issue - November 5, 2009 Category: Infectious Diseases Tags: article PHOTO QUIZ Source Type: journals
Editorial Commentary: Artemisinin Combination Therapy for Malaria: Beyond Good EfficacyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Clinical Infectious Diseases, Volume 49, Issue 11, Page 1638-1640, 1 December 2009.
Source: Clinical Infectious Diseases Latest Issue - November 5, 2009 Category: Infectious Diseases Tags: article EDITORIAL COMMENTARY Source Type: journals
Editorial Commentary: New Advances in the Management of a Long‐Neglected DiseaseEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Clinical Infectious Diseases, Volume 49, Issue 11, Page 1685-1687, 1 December 2009.
Source: Clinical Infectious Diseases Latest Issue - November 5, 2009 Category: Infectious Diseases Tags: article EDITORIAL COMMENTARY Source Type: journals
Editorial Commentary: The Spread of Klebsiella pneumoniae Carbapenemases: A Tale of Strains, Plasmids, and TransposonsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Clinical Infectious Diseases, Volume 49, Issue 11, Page 1739-1741, 1 December 2009.
Source: Clinical Infectious Diseases Latest Issue - November 5, 2009 Category: Infectious Diseases Tags: article EDITORIAL COMMENTARY Source Type: journals
Epidemiology of Catheter‐Related Bloodstream Infections in Patients Receiving Total Parenteral NutritionEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Clinical Infectious Diseases, Volume 49, Issue 11, Page 1769-1770, 1 December 2009.
Source: Clinical Infectious Diseases Latest Issue - November 5, 2009 Category: Infectious Diseases Tags: article CORRESPONDENCE Source Type: journals
Early Experience with High‐Dosage Daptomycin for Prosthetic InfectionsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Clinical Infectious Diseases, Volume 49, Issue 11, Page 1772-1773, 1 December 2009.
Source: Clinical Infectious Diseases Latest Issue - November 5, 2009 Category: Infectious Diseases Tags: article CORRESPONDENCE Source Type: journals
Nephrotoxicity Associated with Intravenous ColistinEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Clinical Infectious Diseases, Volume 49, Issue 11, Page 1773, 1 December 2009.
Source: Clinical Infectious Diseases Latest Issue - November 5, 2009 Category: Infectious Diseases Tags: article CORRESPONDENCE Source Type: journals
IDSA Guidelines for the Diagnosis and Management of Intravascular Catheter‐Related Bloodstream InfectionEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Clinical Infectious Diseases, Volume 49, Issue 11, Page 1770-1771, 1 December 2009.
Source: Clinical Infectious Diseases Latest Issue - November 5, 2009 Category: Infectious Diseases Tags: article CORRESPONDENCE Source Type: journals
Editorial Commentary: To Build a Better Mousetrap: Pitfalls on the Path to Improving Tampon SafetyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Clinical Infectious Diseases, Volume 49, Issue 11, Page 1718-1720, 1 December 2009.
Source: Clinical Infectious Diseases Latest Issue - November 5, 2009 Category: Infectious Diseases Tags: article EDITORIAL COMMENTARY Source Type: journals
Reply to Collins et al and ManianEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Clinical Infectious Diseases, Volume 49, Issue 11, Page 1771-1772, 1 December 2009.
Source: Clinical Infectious Diseases Latest Issue - November 5, 2009 Category: Infectious Diseases Tags: article CORRESPONDENCE Source Type: journals
Book Review: Case Studies in Infectious DiseaseEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Clinical Infectious Diseases, Volume 49, Issue 11, Page 1776, 1 December 2009.
Source: Clinical Infectious Diseases Latest Issue - November 5, 2009 Category: Infectious Diseases Tags: book review Source Type: journals
Africa: Aids Funding at 'Dangerous Turning Point'Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Wavering international support for HIV/AIDS efforts is resulting in funding shortfalls that could wipe out a decade of progress in rolling out AIDS treatment, the international medical and humanitarian organization, Médecins Sans Frontières (MSF), has warned.
Source: AllAfrica News: HIV-Aids and STDs - November 5, 2009 Category: Infectious Diseases Source Type: news
Book Review: The Travel and Tropical Medicine Manual, Fourth EditionEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Clinical Infectious Diseases, Volume 49, Issue 11, Page 1775, 1 December 2009.
Source: Clinical Infectious Diseases Latest Issue - November 5, 2009 Category: Infectious Diseases Tags: book review Source Type: journals
Medical Microbiology: Antimicrobial Susceptibility Testing: A Review of General Principles and Contemporary PracticesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Clinical Infectious Diseases, Volume 49, Issue 11, Page 1749-1755, 1 December 2009.
An important task of the clinical microbiology laboratory is the performance of antimicrobial susceptibility testing of significant bacterial isolates. The goals of testing are to detect possible drug resistance in common pathogens and to assure susceptibility to drugs of choice for particular infections. The most widely used testing methods include broth microdilution or rapid automated instrument methods that use commercially marketed materials and devices. Manual methods that provide flexibility and possible cost savings include th...
Source: Clinical Infectious Diseases Latest Issue - November 5, 2009 Category: Infectious Diseases Tags: article MEDICAL MICROBIOLOGY Source Type: journals
Editorial Commentary: Widening Differences in Acute Otitis Media Study PopulationsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Clinical Infectious Diseases, Volume 49, Issue 11, Page 1648-1649, 1 December 2009.
Source: Clinical Infectious Diseases Latest Issue - November 5, 2009 Category: Infectious Diseases Tags: article EDITORIAL COMMENTARY Source Type: journals
Mauritania: Don't Abandon Us, HIV-Positive Community Tells DonorsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
People living with HIV in Mauritania are voicing their concerns about the suspension of HIV/AIDS funding by the World Bank and the Global Fund to fight AIDS, Tuberculosis and Malaria. They feel powerless in the face of the decisions, of which they are suffering the consequences.
Source: AllAfrica News: HIV-Aids and STDs - November 5, 2009 Category: Infectious Diseases Source Type: news
